Cell Therapy

Top Story

CAR T-cell therapies may be cost-effective for patients with lymphoma subtype

July 23, 2019

Read the Perspective from Nirav Shah, MD

In the Journals

CD19-specific CAR T-cell therapy feasible for aggressive non-Hodgkin lymphoma

July 23, 2019
CD19-specific chimeric antigen receptor T-cell therapy after high-dose chemotherapy and autologous stem cell transplant appeared feasible for patients with relapsed or…
Meeting NewsVideo

VIDEO: Initial results of ZUMA-3 trial ‘highly encouraging’ for relapsed, refractory leukemia

July 21, 2019
CHICAGO — Bijal D. Shah, MD, associate professor in the department of malignant hematology at Moffitt Cancer Center, spoke with HemOnc Today at ASCO Annual…
Meeting News

Nonengineered T-cells may be ‘clinically meaningful’ for pancreatic cancer

July 19, 2019
More than half of patients with pancreatic adenocarcinoma showed clinical responses when treated with an investigational multiantigen-specific T-cell therapy, according…
More Headlines »
CME

Acute Lymphoblastic Leukemia Posters and Abstracts from San Diego

This activity is supported by educational funding provided by Amgen.

In this CME activity Elias Jabbour, MD, provides his perspectives on key posters presented at the American Society of…
More »
Video
Meeting News

VIDEO: Early steroids may reduce severe side effects among patients who receive CAR T-cell therapy

July 13, 2019
More »
CME ABIM MOC

Ace the Case: A 9-Year-Old Girl With Bruising, Fatigue, Left Hip Pain, and Intermittent Fever for 2 Weeks

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of childhood leukemia.
More »